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Report of a Workshop on Large Whale Medical Intervention - Indications and Technology
Development
Sponsors:  Woods Hole Oceanographic Institution, Center for Coatal Studies, New England Aquarium
Location:  Carriage House, Woods Hole Oceanographic Institution, Woods Hole MA 02543
Date:  Monday February 7th 2000
Steering Committee: Michael Moore1, Andrew Stamper2, Scott Kraus2,. Roz Rolland3
1Biology Department, Woods Hole Oceanographic Institution, 2New England Aquarium, 3Tufts
University Veterinary School
Address for Correspondence:  Michael Moore, MS 33 WHOI, Woods Hole MA 02543
mmoore@whoi.edu  tel:508 289 3228 fax:508 457 2134
Agenda
900 Welcome and Introduction - Michael Moore, WHOI
915 Introduction to right whale disease issues including review of recent     potential patients
Scott Kraus, New England Aquarium
0945 The Federal perspective - Dana Hartley, NMFS
1000 Review of need for restraint and sedation during disentanglement efforts- Stormy Mayo
and  Dave Mattila, Center for Coastal Studies, Provincetown, MA
1030 Break
1100 Review of current therapeutics and sedation in marine mammals Andy Stamper, New
England Aquarium and  Mike Stoskopf N Carolina State U.
1130   Round table discussion 1: drug choice and formulation options for large whales:
sedatives, local anesthetics, glucocorticoids and antibiotics - Chair Andy Stamper
1230 Lunch
1330 Round table discussion 2: of physical restraint issues for large whales - potential solutions
- Chair Dave Mattila
1430 Round Table Discussion 3 : Design of hardware needs given expected drug formulations
- Chair Terry Hammar, WHOI
1530 Break
1550    Diagnostic priorities – Roz Rolland, Tufts Veterinary School
1600    Summary - Michael Moore and Scott Kraus
New England
Aquarium
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Executive Summary
The agenda of this workshop was to evaluate the indications for medical intervention in
large whales, especially northern right whales, and to develop the technology appropriate for
applications that appeared to be clinically and ethically appropriate.  A review was presented of
ship strike, fishing gear entanglement, reproductive failure and chronic skin disease evident in
the populations of NW Atlantic right whales.  Then, before proceeding into specific issues we
reviewed the need for proposed protocols to be reviewed by the NMFS permit office to facilitate
case by case requests for permits for emergency intervention by qualified veterinarians.  The
current system for physical restraint to enable disentanglement of right whales was then
described.  The available sedation and antibiotic agents were reviewed in the context of potential
application to large whales.  Through the workshop a consensus was reached that sedation prior
to a disentanglement effort should be seriously considered on a case by case basis.  The aim
would be to minimize the substantial risk of injury or death to human operators who are
attempting to disentangle the whale and to maximize the chance of a complete and minimally
stressful disentanglement.  The benzodiazepine drug Midazolam has been used successfully in
captive free swimming small odontocetes, inducing a certain incoordination but no loss of
respiratory control.  Therefore the next step is to establish the efficacy and toxicity of this drug in
non-endangered mysticetes, such as beached gray whales prior to euthanasia and in entangled
humpbacks during disentanglement efforts.   At the same time safe intramuscular delivery
systems need to be developed that are capable of delivering about 20ml per injection site.  The
case for use of antibiotics was less clear.  Obstacles include the absence of clear diagnostic
indication for such therapy, the large volumes required and the frequency of administration.  The
next steps were therefore defined as:  a) testing of Midazolam at doses in the range of 0.02 – 0.04
mg/kg in mysticetes as practical and as permitted by NMFS, b) development of ballistic systems
to deliver this drug intramuscularly in animals with up to 25 cm of blubber thickness and c)
analysis of available blubber thickness data to select optimal injection sites.  Once these two
steps are complete the use of sedation prior to disentanglement efforts should then be tested.
These developments must be accompanied by further development of physical restraint systems
as currently underway at the Center for Coastal Studies.  Discussion of these issues included the
possibility of head restraint, inflatable dry docks, and the current prototype tail harness.  The
potential for routine diagnostic evaluation of sedated animals during disentanglement was also
discussed.  Blood samples allowing surveys of serology were thought to yield the most important
information in terms of infectious diseases that may impact the reproductive success of the
population. Hematology and serum chemistry panels are also desirable to assess the physical
state of the patient, to help to interpret the response to sedation and to establish some baseline
values for this species.  Therefore a further requirement is to develop a system to obtain blood
samples from a restrained whale. Culture and sensitivities of gross external wounds, and possible
biopsies thereof, were also suggested to assist in the goal of more complete diagnostics, and to
assist in the decisions concerning antibiotic usage.
Background
This one day interdisciplinary workshop, attended by 12 veterinarians 11 whale
biologists, an engineer and the NMFS Regional Stranding Coordinator, was convened by
Michael Moore, with financial support from the Woods Hole Oceanographic Institution Cecil
and Ida Green Technology Innovation Fund.  The goal was to examine ways in which veterinary
medical techniques could assist in efforts to mitigate right whale mortality.  In particular the
indications and technology for the use of sedation during disentanglement efforts and antibiotic
therapy for wounds after disentanglement were considered.
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Scott Kraus reviewed the key features of impacts on right whale survival that have some
potential for mitigation.  Fifty percent of North Atlantic right whale mortality results from ship
strikes and gear entanglement.  Ship strikes are the commonest cause of human induced
mortality.  They also can cause large open wounds resulting in severe scars on some survivors.
At least sixty percent of the population has been entangled at least once based upon an analysis
of the presence of typical scars.   Their skim feeding habit increases the risk of serious
entanglement.  Disentanglement efforts represent a major chance to mitigate this mortality and
morbidity factor.  In addition there is a significant un-diagnosed reduction in reproductive
success in northern right whales as compared to southern right whales.  This has been
exacerbated in recent years with the calving index increasing.  Right whale calves are born at
4m, growing to 9m in the first year before weaning.  Adult females can be up to 13m with males
a meter shorter. The recent case of right whale #2030 was discussed.  It was found entangled in
Spring 1999, partially disentangled in September, but the tightest line remained, cutting through
the blubber over the back between the axillae.  It died in October as a result of trauma from the
entanglement.  Permits were sought and granted for antibiotic therapy in Canada, but the permit
was not used after the disentanglement effort failed. The ability to safely sedate this animal
would have substantially increased the chance of a full disentanglement.   Northern right whales
also exhibit a variety of chronic skin lesions.  Attempts at biopsy of these lesions for diagnosis
have failed to date.  Thus there is significant entanglement related trauma and undiagnosed skin
and reproductive health issues in this population that warrant whatever medical investigation,
and treatment that can be delivered ethically and safely.  Samples currently available for testing
include: epidermal/dermal biopsies, feces, exhaled breath, and ultrasound measures of blubber
thickness.
Dana Hartley then discussed the legal aspects of any future medical intervention with
large whales.  This was material sent to Dana for the workshop from Teri Rowles, an invitee
unable to attend the workshop.  Entangled whales are not considered stranded unless anchored.
Thus free swimming entangled whales are not covered by regional Letters of Agreement for
stranding management. Disentanglement of large whales is currently only permitted by the
Center for Coastal Studies and qualified members of the Disentanglement Network.  This is true
for both anchored & free-swimming whales.  The stranding network may be allowed to
disentangle smaller, anchored cetaceans on a case by case basis under their Letter of Agreement
with NMFS.  Permit requests for medical intervention would be considered by NMFS on a case
by case basis as an emergency action under the Marine Animal Health and Stranding Response
Permit. There was discussion on what type of case would qualify for medical intervention under
this permit.  Initially intervention would probably only be authorized for the more extreme cases,
but that as protocols are developed through research (i.e., w/ gray whales), perhaps sedation
could be used in "less dire" cases. It was hoped that standard protocols could be submitted to
NMFS for peer review so that granting of emergency requests would be facilitated, to allow
action by a pre-approved list of qualified veterinarians.
Stormy Mayo then reviewed the current Center for Coastal Studies techniques for
disentanglement. The basic approach, developed for humpback whales, is to increase their drag
with buoys and drogues to slow them down sufficiently to allow gear removal.  This has also
been successful in right whales in 3/7 cases in the past 7 years, but the increased stamina, power
and irritability of right whales has made this approach at times extremely dangerous to humans
and not always successful.  To date no serious human injuries have been sustained.  A major
component of the recent successful disentanglement efforts has been the substantial logistic
support received from the US Coast Guard.  Systems developed to stop whales include hooks,
grapples, floats, boats and drogues.  Attachment of satellite-monitored transmitters in buoys to
the gear has enabled efforts to continue for multiple days, given adequate weather by keeping
track of whales and gear.  David Mattila then reviewed current efforts to develop a tail harness
for animals where the entanglement involved anterior structures and offered no purchase on the
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tail.  He also described the concept of a device that was dropped in front of the flukes and had
asymmetrical vanes that spun together behind the animal. Discussion ensued on the relative
merits of controlling the tail vs./ the head.  Tools to approach the latter could include a large
hoop net, some form of twitch encircling the rostrum, or a seine net.  The idea of an inflatable
dry dock type system was also raised.  The general assertion that cetacea tend to stop when held
was discussed with the hope that this would be applicable to right whales.  Experience is
equivocal on this point.  The general consensus was that physical restraint efforts would be
substantially helped with some level of chemical sedation that lasted for periods of up to a few
hours.  It was agreed that to be effective a sedative has to be given before the animal is
stimulated by disentanglement efforts.  Sedatives are better at preventing excitement than
reducing it.
Andrew Stamper then described the characteristics desirable in candidate sedatives:  large
margin of safety, low volume, single effective dose, reversible, low cost, no adverse reactions
and easy to obtain.  Requirements of an antibiotic would be low volume and cost, broad
spectrum and bactericidal.  Challenges for dose calculation include an accurate prediction of
weight, appropriate use of allometric scaling, variation in physiologcal condition, dive response
induced changes in regional blood flow, and pooling of lipid soluble drugs in blubber.  There
could also be risks to fetuses and suckling calves.  Sedation could include the risk of inhalation
under water.  Challenges for antibiotic therapy include the volume to be administered with the
resultant risk of sterile necrosis, the necessary frequency of administration to obtain therapeutic
levels, and the potential for adverse reactions such as solar dermatitis with some medications.
Delivery systems to discuss include dart syringes, biobullets, lyophilisation, oral, absorption
across nasal mucus membranes via instillation into the blowhole and skin patches.  Michael
Stoskopf then discussed the issue of pharmacokinetics, in terms of partitioning and the chemical
nature of specific drugs.  He discussed the use of allometric scaling, and concluded that
ultimately we need to use all that we know of specific drugs in other species, and then make an
empirical assessment of dose, effect and survival to arrive at an appropriate protocol.  The
potential for antibiotic therapy was discussed, and the concern of the potential for development
of multiple drug resistant bacteria was suggested as a barrier to the concept of using antibiotics at
all.  Others disputed this and the issue was not fully resolved.  It was felt that if specific
conditions such as Brucella were to be diagnosed in the future then the case for antibiotic use
would be stronger, but that for entanglement induced wounds, removal of the foreign body was
the primary goal, to allow resultant healing.
David Brunson then discussed the nature of Benzodiazepine group: anxiolytic, reversible,
mild sedatives and safer than most other drugs.    They work well in some species and not at all
in others.  Jim McBain then offered that in his experience 20ml injection per volume avoided
major tissue necrosis.  He reported that Midazolam, a Benzodiaopine derivative induced
sedation, but not loss of respiratory function in odontocetes – “they appear drunk but functional”.
Midazolam was agreed to be the best candidate drug for sedation of large whales.  A dose of 0.02
to 0.04 mg/kg was agreed as the be t starting dose.  This is a water-soluble drug routinely
available at 5mg/ml.  It can also be theoretically be lyophilized and reconstituted as 20 mg/ml .
Thus adult right whales ranging in weight from 20,000 to 60,000 kg would require one to many
injections of 20 ml depending upon determination of the optimal dose and estimated weight.  It
seemed sensible to base our technology discussion on the assumption that multiple 20 ml units
would need to be delivered.  A brief discussion of immobilization by the use of neuromuscular
agents resulted in the conclusion that this was probably not appropriate in these free swimming
situations.  Not presented at the workshop but relevant to this discussion was subsequent analysis
of available necropsy data showing simple relationships allowing estimation of approximate
body weight from age, or total length or fluke width (M. Moore pers. comm.).
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Candidate situations for testing sedative use in mysticetes were then discussed.  Stranded
large whales deemed needing euthanasia would seem good initial candidates. Acknowledging
that initial doses selected may be lethal, it was suggested that sedation prior to euthanasia has a
good ethical basis, thus a relatively high dosage of Midazolam should be given in the first
instance, with the resultant impact on heart rate, body and eye movement and survival recorded.
It was noted that shocked stranded mysticetes might not be good models for entangled right
whales, and that permits should also then be sought for the use of Midazolam on entangled
humpback and minke whales.   Jim McBain felt that the use of Midazolam in a right whale was
unlikely to represent a serious risk of harm.
David Mattila then opened a discussion of physical restraint.  Right whales seem to have
a unique ability to tow gear, boats and drogues for long periods of time under substantial loads,
without slowing down.   The Center for Coastal Studies has focussed their efforts on restraint by
the tail using small boats and drag systems.  Many at the workshop were interested in restraint
methods aimed on the head region.  Stormy Mayo related that Navy Seals had planned to deploy
a cargo net over the head of a right whale in the Delaware River.  This had not been attempted.
The concern was then raised that there would be substantial drag in trying to deploy a hoop net at
the scale required for a right whale.   The discussion then moved to the relative size of the whale
and the vessel attempting restraint.  The group acknowledged that ultimately the vessels best
suited for catching large whales are to be found in the catcher boat designs of the whaling fleets.
The suggestion was made that any system of restraint be tested on floating dead whales first.   In
conclusion it seemed that the existing small boat based system, that had been proven to be
practical and affordable, could be made substantially safer for humans and whale with a safe
sedation protocol.
A discussion was also held on the risk of the capture myopathy syndrome.  It was agreed
that there was an inevitable risk of this in situations where an animal was severely stressed in
handling or chronic entanglement.
Terry Hammar then led a discussion on the possible avenues for drug delivery.  Michael
Moore demonstrated the prototype injection system designed for use with a cantivlevered 40’
pole to deliver large volumes (one liter).  It was agreed that operator safety would be greatest
with a ballistic device.  The risk of complications with needles suggested that slugs fired in to the
dorsal muscle mass may be the most effective.   We agreed to limit the discussion to delivery of
one or more 20ml doses or the development of solid “biobullets or biobolts”.  The question of the
ability to lyophilize a drug for delivery was also discussed.  Concern was raised that the powder
would not be absorbed rapidly enough.  Larry Dunn emphasized that the pharmaceutical industry
needs to be given specific formulation requests before they can be of assistance.    Discussion
then covered the possibility of drugs via the blowhole to allow absorption across the nasal mucus
membranes.  There was no consensus delivering that this was practical, with major concerns of
delivery, poor penetration and exhalation voiding any drug introduced resulting in both poor
efficacy and potential danger of inhalation by project personnel.  The question of attaching a line
first, or sedating first was also raised.  It was concluded that the specific situation would dictate
the precise protocol.  This discussion was concluded with a resolution that Michael Moore,
David Brunson and Terry Hammar would confer on further development of the available
ballistic technology.  The systems developed for Discovery tag delivery should also be revisited,
as should available information on the biocompatability of different materials that may be used
in drug delivery.
Roz Rolland then briefly discussed the important diagnostic investigations that might be
attempted in a sedated whale.  Clinical observations before, during and after sedation should
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include awareness level, respiration character and rate and expiration/ inspiration interval, and
changes in tail, flipper and eye movement.  Attachment of an acoustic or electric cardiac monitor
by suction cup would also be important if possible.    Blood samples should be collected if
possible for physiological and health assessment.  Desirable parameters include hematology,
serum chemistry and serology for a targeted list of infectious disease of concern.
 It was also agreed that Beth Turnbull, Roz Rolland, Mike Stoskopf, and Greg Early
would assemble a sampling kit for the Center for Coastal Studies for the event where a blood
sample could be drawn nd cultures and biopsies may be taken.  After the meeting Mike
Stoskopf provided a prototype design for a pole based blood sampling system.  Moore, Hammar,
Brunson and Stoskopf will work on this design.
WORK PLAN (written by Michael Moore in writing up the report after the workshop)
1. Moore to submit draft report to attendees for edits.  Final report then to attendees for
approval.
2. Circulate final report to all invitees and other interested parties, including the Eubalaena
email list encouraging feedback and comment.
3. Develop sampling kit for CCS to carry in case the opportunity to collect blood samples
cultures and biopsies arises. ( Turnbull, Early, Stoskopf and Mattila).  Need to submit blood
sampling, culture and biopsy protocol to NMFS for addition to CCS permit.  Mattila and
Stamper/Turnbull to take this lead.
4. Investigate the available ballistic systems to modify for remote i/m delivery of 20 ml fluid or
powder 30 cm deep (Moore, Stamper, Brunson, Hammar and Brown).
5. Solicit stranding networks to sedate large whales with Midazolam prior to euthanasia making
the observations recommended above.  This request should probably be made by Teri Rowles.
Data should be collated and reported in peer reviewed literature.  Frances Gulland at the Marine
Mammal Center in Sausolito will probably get the opportunity to do this on gray whales, so
maybe she should be the coordinator of this data set.
6. Prepare and submit to NMFS detailed protocols for use of sedation in disentanglement for
potential addition to CCS permit.  Administer sedation to entangled humpbacks and minkes.
Kraus/ Stamper/ Mattila
7. Assuming work develops as planned add sedation to routine disentanglement protocol for all
large whales including right whales.
8. Continue working discussion and research /assess validity of antibiotic therapy in whales.
Pertinent data should be collated and reported in peer review literature.
Suggest a working group be formed to carry out this plan:
Moore, Hammar, Kraus, Early, Mattila, Stamper, Rowles, Gulland, Brunson,
Attendees
Rachel Blackmer – Veterinary Clinician
508 362 0111
rblackmer@earthlink.net
Cape Wildlife Center, Humane Society of the US, West Barnstable, MA
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Moira Brown – Right Whale Biologist
5084873622
mbrown@coastalstudies.org
Center for Coastal Studies, Box 1036, Provincetown, MA 02657
David Brunson – Veterinary Anesthesiologist
608-273-0813
brunsond@svm.vetmed.wisc.edu
School of Vet Med, U. Wisconsin, Madison, WI 53706
Paul Calle – Veterinary Clinician
718 220 7104  fax 718-220-7126
pcalle@wcs.org
Wildlife Conservation Society, 185th and S. Blvd, Bronx, NY 10460-1099
Phillip Clapham – Large Whale Biologist
5082952316
Phillip.Clapham@noaa.gov
National Marine Fisheries Service, Woods Hole, MA 02543
Jim Dasbach - Veterinarian
5082746271
jdasbach@ifaw.org
International Fund for Animal Welfare, 411 Main St Yarmouthport, MA 02675
Karen Moore Dourdeville – Large Whale Biologist
508 748 2878
moorek@capecod.net
Box 627, Marion MA 02738
Larry Dunn – Veterinary Clinicain
8605725955 x103
ldunn@mysticaquarium.org
Mystic Aquarium, 55 Coogan Blvd., Mystic CT 06355-1997
Greg Early – Whale Biologist
617 973 5246
New England Aquarium, Central Wharf, Boston MA 02110
Jeff Foster – Program Manager, Keiko Project
805 899 8899
jfoster@oceanfutures.com
Ocean Futures, 325 Chapala St, Santa Barbara, CA 93101
Terrence  Hammar - Engineer
5082892891
thammar@whoi.edu
MS 19 Woods Hole Oceanographic Institution,Woods Hole MA 02543
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Dana Hartley – Regional Stranding Coordinator
5084952090
dana.hartley@noaa.gov
National Marine Fisheries Service, Woods Hole 02543
Brenda Jensen – Doctoral Student
508 289 3215
bjensen@whoi.edu
MS 32 Woods Hole Oceanographic Institution, Woods Hole, MA 02543
Scott  Kraus – Right Whale Biologist
617 973 5457
skraus@neaq.org
New England Aquarium, Central Wharf, Boston MA 02110
David Mattila – Large Whale Biologist
508 487 3622
dmattila@coastalstudies.org
Director of Disentanglement, Center for Coastal Studies, Box 1036, Provincetown, MA 02657
Stormy Mayo – Right Whale Biologist
508 4873622 x18
stormym33@pobox.com
Center for Coastal Studies, Box 1036, Provincetown, MA 02657
Jim McBain – Veterinary Clinician
6192263833
James.McBain@anheuser-busch.com
Sea World of Ca., 1720 S Shores Rd, San Diego CA 92109
Carolyn  Miller – Doctoral Student
508 289 3395
cmiller@whoi.edu
MS 33 Woods Hole Oceanographic Institution, Woods Hole, MA 02543
Michael Moore – Veterinarian and Right Whale Biologist
508 289 3228
mmoore@whoi.edu
MS 33 Woods Hole Oceanographic Institution, Woods Hole, MA 02543
Roz  Rolland - Veterinarian
508 887 4775
rrolland@infonet.tufts.edu
Center for Conservation Med. Tufts Vet Sch. 200 Westborough Rd N. Grafton MA 01536
Andrew Stamper – Veterinary Clinician
617 973 0227
astamper@neaq.org
New England Aquarium, Central Wharf, Boston MA 02110
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David St Aubin – Whale Biologist
8605725955 x102
dstaubin@mysticaquarium.org
Mystic Aquarium, 55 Coogan Blvd., Mystic CT 06355-1997
Mike Stoskopf – Veterinary Pharmacologist
9195136230
Michael_Stoskopf@ncsu.edu
NC State University, 4700 Hillsborough St, Raleigh, NC 27606
Mark Trimm – Veterinary Clinician
305 274 7248
MAUYAAK@aol.com
Miami Seaquarium, 7749 SW 118 PL. Miami FL. 33183
Beth  Turnbull – Veterinary Pathologist
6179736714
bsturnbull@aol.com
New England Aquarium, Central Wharf, Boston MA 02110
